Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release Mar 01 2024

· Issued by Aurobindo Pharma Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-01-2024-6

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 01, 2024, titled "Aurobindo Pharma receives USFDA approval for Fingolimod Capsules, 0.5 mg".

View Attachment

6ix hasn’t read this filing yet.

Aurobindo Pharma Ltd on 6ix

Earlier from Aurobindo Pharma

Later from Aurobindo Pharma

All Aurobindo Pharma news releases